The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic ...

Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

Samsung is proceeding with an investment in Averr BioTechnology (Averr Bio), a U.S.-based biotech company specializing in ...

Creative Medical Technology Holdings, Inc. is a clinical-stage biotechnology company pioneering regenerative medicine solutions across multiple indications. The Company leverages cutting-edge cell ...

In advance of CPhI, Cambrex and Wilmington PharmaTech both just announced big investments in US plants that make active ...

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

Building off the momentum of a historic fundraising year and the hiring of former State of Connecticut Chief Manufacturing Officer Paul Lavoie, the University has raised $10 million – supported by a ...

Still, the recently released 2025-30 Arizona Bioscience Roadmap, as well as several academic, community and local government ...